The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing therapeutic potential in patients with spinocerebellar…
SAN FRANCISCO and SUZHOU, China, Nov. 4, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company…
Convening in Oklahoma City brought together more than 200 stakeholders, spanning leading businesses, organizations, governments and philanthropies, focused on helping…
SAN CLEMENTE, Calif., Nov. 4, 2025 /PRNewswire/ — Angelalign Technology Inc. (6699.HK) (“Angel”) today announced the expansion of its flexible iOrtho®…